Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-9788
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases ; day:5 ; month:9 ; year:2016 ; pages:1-7
Drugs - real world outcomes ; (5.9.2016), 1-7
- Urheber
-
Mourot-Cottet, Rachel
- Beteiligte Personen und Organisationen
-
Maloisel, Fréderic
Severac, François
Keller, Olivier
Vogel, Thomas
Tebacher, Martine
Weber, Jean-Christophe
Kaltenbach, Georges
Gottenberg, Jacques-Eric
Goichot, Bernard
Sibilia, Jean
Korganow, Anne-Sophie
Herbrecht, Raoul
Andres, Emmanuel
SpringerLink (Online service)
- DOI
-
10.1007/s40801-016-0091-4
- URN
-
urn:nbn:de:1111-201610045365
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mourot-Cottet, Rachel
- Maloisel, Fréderic
- Severac, François
- Keller, Olivier
- Vogel, Thomas
- Tebacher, Martine
- Weber, Jean-Christophe
- Kaltenbach, Georges
- Gottenberg, Jacques-Eric
- Goichot, Bernard
- Sibilia, Jean
- Korganow, Anne-Sophie
- Herbrecht, Raoul
- Andres, Emmanuel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Uncovering the mechanism of troglitazone-mediated idiosyncratic drug-induced liver injury with individual-centric models
An original donor-dependent spheroid system for the prediction of idiosyncratic drug-induced liver injury risk
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016
Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review
Idiosyncratic drug-induced liver injury related to use of novel selective androgen receptor modulator RAD140 (Testalone): a case report
Human leucocyte antigen genetics in idiosyncratic drug-induced liver Injury with evidence based on the Roussel Uclaf causality assessment method
Advances in idiosyncratic drug-induced liver injury issues: new clinical and mechanistic analysis due to Roussel Uclaf Causality Assessment Method use
Is idiosyncratic risk conditionally priced?
Financial Crises: Systemic or Idiosyncratic
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Uncovering the mechanism of troglitazone-mediated idiosyncratic drug-induced liver injury with individual-centric models
An original donor-dependent spheroid system for the prediction of idiosyncratic drug-induced liver injury risk
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016
Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review
Idiosyncratic drug-induced liver injury related to use of novel selective androgen receptor modulator RAD140 (Testalone): a case report
Human leucocyte antigen genetics in idiosyncratic drug-induced liver Injury with evidence based on the Roussel Uclaf causality assessment method
Advances in idiosyncratic drug-induced liver injury issues: new clinical and mechanistic analysis due to Roussel Uclaf Causality Assessment Method use
Is idiosyncratic risk conditionally priced?
Financial Crises: Systemic or Idiosyncratic
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Uncovering the mechanism of troglitazone-mediated idiosyncratic drug-induced liver injury with individual-centric models
An original donor-dependent spheroid system for the prediction of idiosyncratic drug-induced liver injury risk
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016
Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review
Idiosyncratic drug-induced liver injury related to use of novel selective androgen receptor modulator RAD140 (Testalone): a case report
Human leucocyte antigen genetics in idiosyncratic drug-induced liver Injury with evidence based on the Roussel Uclaf causality assessment method
Advances in idiosyncratic drug-induced liver injury issues: new clinical and mechanistic analysis due to Roussel Uclaf Causality Assessment Method use
Is idiosyncratic risk conditionally priced?